BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26091081)

  • 21. Sequence and phylogenetic analyses of human rotavirus strains: comparison of VP7 and VP8(∗) antigenic epitopes between Tunisian and vaccine strains before national rotavirus vaccine introduction.
    Mouna BH; Hamida-Rebaï MB; Heylen E; Zeller M; Moussa A; Kacem S; Van Ranst M; Matthijnssens J; Trabelsi A
    Infect Genet Evol; 2013 Aug; 18():132-44. PubMed ID: 23684631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative characteristics of the VP7 and VP4 antigenic epitopes of the rotaviruses circulating in Russia (Nizhny Novgorod) and the Rotarix and RotaTeq vaccines.
    Morozova OV; Sashina TA; Fomina SG; Novikova NA
    Arch Virol; 2015 Jul; 160(7):1693-703. PubMed ID: 25944143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial.
    Groome MJ; Fairlie L; Morrison J; Fix A; Koen A; Masenya M; Jose L; Madhi SA; Page N; McNeal M; Dally L; Cho I; Power M; Flores J; Cryz S
    Lancet Infect Dis; 2020 Jul; 20(7):851-863. PubMed ID: 32251641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral immunization of mice with Lactococcus lactis expressing the rotavirus VP8* protein.
    Rodríguez-Díaz J; Montava R; Viana R; Buesa J; Pérez-Martínez G; Monedero V
    Biotechnol Lett; 2011 Jun; 33(6):1169-75. PubMed ID: 21302132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation and preclinical studies with a trivalent rotavirus P2-VP8 subunit vaccine.
    Lakatos K; McAdams D; White JA; Chen D
    Hum Vaccin Immunother; 2020 Aug; 16(8):1957-1968. PubMed ID: 31995444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engineering and expression of a human rotavirus candidate vaccine in Nicotiana benthamiana.
    Pêra FF; Mutepfa DL; Khan AM; Els JH; Mbewana S; van Dijk AA; Rybicki EP; Hitzeroth II
    Virol J; 2015 Dec; 12():205. PubMed ID: 26626122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral immunization with live Lactococcus lactis expressing rotavirus VP8 subunit induces specific immune response in mice.
    Marelli B; Perez AR; Banchio C; de Mendoza D; Magni C
    J Virol Methods; 2011 Jul; 175(1):28-37. PubMed ID: 21530589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity.
    Ciarlet M; Crawford SE; Barone C; Bertolotti-Ciarlet A; Ramig RF; Estes MK; Conner ME
    J Virol; 1998 Nov; 72(11):9233-46. PubMed ID: 9765471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant influenza A virus hemagglutinin HA2 subunit protects mice against influenza A(H7N9) virus infection.
    To KK; Zhang AJ; Chan AS; Li C; Cai JP; Lau CC; Li CG; Jahan AS; Wu WL; Li L; Tsang AK; Chan KH; Chen H; Yuen KY
    Arch Virol; 2015 Mar; 160(3):777-86. PubMed ID: 25616843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wa-VP4* as a candidate rotavirus vaccine induced homologous and heterologous virus neutralizing antibody responses in mice, pigs, and cynomolgus monkeys.
    Luo G; Zeng Y; Sheng R; Zhang Z; Li C; Yang H; Chen Y; Song F; Zhang S; Li T; Ge S; Zhang J; Xia N
    Vaccine; 2024 May; 42(15):3514-3521. PubMed ID: 38670845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Yeast expression of the VP8* fragment of the rotavirus spike protein and its use as immunogen in mice.
    Andrés I; Rodríguez-Díaz J; Buesa J; Zueco J
    Biotechnol Bioeng; 2006 Jan; 93(1):89-98. PubMed ID: 16193515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a bivalent recombinant vaccine candidate targeting norovirus and rotavirus: Antibodies to rotavirus NSP4 exert antidiarrheal effects without virus neutralization.
    Cao H; Wu J; Luan N; Wang Y; Lin K; Liu C
    J Med Virol; 2022 Aug; 94(8):3847-3856. PubMed ID: 35474320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. VP8* antigen produced in tobacco transplastomic plants confers protection against bovine rotavirus infection in a suckling mouse model.
    Lentz EM; Mozgovoj MV; Bellido D; Dus Santos MJ; Wigdorovitz A; Bravo-Almonacid FF
    J Biotechnol; 2011 Nov; 156(2):100-7. PubMed ID: 21893114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles.
    Lappalainen S; Tamminen K; Vesikari T; Blazevic V
    Hum Vaccin Immunother; 2013 Sep; 9(9):1991-2001. PubMed ID: 23777748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does a monovalent inactivated human rotavirus vaccine induce heterotypic immunity? Evidence from animal studies.
    Jiang B; Wang Y; Glass RI
    Hum Vaccin Immunother; 2013 Aug; 9(8):1634-7. PubMed ID: 23744507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice.
    Bertolotti-Ciarlet A; Ciarlet M; Crawford SE; Conner ME; Estes MK
    Vaccine; 2003 Sep; 21(25-26):3885-900. PubMed ID: 12922123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. mRNA-Based Vaccines Are Highly Immunogenic and Confer Protection in the Gnotobiotic Pig Model of Human Rotavirus Diarrhea.
    Hensley C; Roier S; Zhou P; Schnur S; Nyblade C; Parreno V; Frazier A; Frazier M; Kiley K; O'Brien S; Liang Y; Mayer BT; Wu R; Mahoney C; McNeal MM; Petsch B; Rauch S; Yuan L
    Vaccines (Basel); 2024 Mar; 12(3):. PubMed ID: 38543894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization of Mice by Rotavirus NSP4-VP6 Fusion Protein Elicited Stronger Responses Compared to VP6 Alone.
    Afchangi A; Arashkia A; Shahosseini Z; Jalilvand S; Marashi SM; Roohvand F; Mohajel N; Shoja Z
    Viral Immunol; 2018 Apr; 31(3):233-241. PubMed ID: 29185875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivated human rotavirus vaccine induces heterotypic antibody response: correction and development of IgG avidity assay.
    Velasquez DE; Wang Y; Jiang B
    Hum Vaccin Immunother; 2015; 11(2):531-3. PubMed ID: 25692974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced protective immune response to PCV2 subunit vaccine by co-administration of recombinant porcine IFN-γ in mice.
    Wang YP; Liu D; Guo LJ; Tang QH; Wei YW; Wu HL; Liu JB; Li SB; Huang LP; Liu CM
    Vaccine; 2013 Jan; 31(5):833-8. PubMed ID: 23219694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.